drugset / Trial / NCT06106334

Effect of Administration of Itraconazole on the Pharmacokinetics of S-309309 in Healthy Participants

NCT06106334 ↗

Phase 1 Completed 14 enrolled Shionogi
NaCrossoverOpen-labelTreatment

Summary

The primary purpose of this study is to determine the effect of repeated administration of itraconazole on the pharmacokinetic (PK) profile of S-309309; and the PK of S-309309 following administration of S-309309 alone and co-administration with itraconazole

Timeline

Start
2023-11-15
Primary completion
2023-12-08
Completion
2024-02-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — Oral
Subject S-309309 Unknown — Oral

Indications